Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Operating Leases (2022 - 2025)

Celularity (CELU) has disclosed Operating Leases for 4 consecutive years, with $26.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Leases rose 1.34% to $26.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $26.8 million, a 1.34% increase, with the full-year FY2024 number at $26.5 million, up 1.42% from a year prior.
  • Operating Leases was $26.8 million for Q3 2025 at Celularity, roughly flat from $26.7 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $30.5 million in Q1 2022 to a low of $26.1 million in Q3 2023.
  • A 4-year average of $27.2 million and a median of $26.7 million in 2025 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: fell 7.92% in 2023, then increased 1.45% in 2024.
  • Celularity's Operating Leases stood at $28.0 million in 2022, then dropped by 6.46% to $26.2 million in 2023, then increased by 1.42% to $26.5 million in 2024, then rose by 0.97% to $26.8 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Operating Leases are $26.8 million (Q3 2025), $26.7 million (Q2 2025), and $26.6 million (Q1 2025).